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nalysis of the causes and extent of 
initial diagnosis by invasive method 
of amniocentesis is very important in 
order to investigate the chromosomal abnormalities and 
other severe congenital defects to provide genetic coun-
seling of pregnant women. In Ardebil province (northwest 
of Iran), due to failures such as infertility, repeated abor-
tion and embryonic anomalies, a study was conducted to 
analyze amniotic fluid samples of pregnant mothers, to 
determine amniocentesis indications, to determine the 
frequency and types of chromosomal abnormalities and 
adaptability of indication of amniocentesis in pregnant 
women. This retrospective descriptive-analytic study was 
conducted on all amniocentesis files (715 referrals to the 
only Amniocentesis Center of Ardebil province) over 2 
years. Data were collected by examining the patients’ file. 
The variables included: maternal age, indication of amnio-
centesis, chromosomal anomalies, and type of chromo-
somal abnormalities. After completing the data, the data 
were analyzed using descriptive and analytical statistics in 
SPSS software version 16. Data analysis showed that the 
most common cause of amniocentesis was a positive re-
sult in maternal serum screening (58.04%). Chromosomal 
abnormalities were observed in 5.5%. 56.4% of chromo-
somal abnormalities were the type of change in number 
(including trisomy 21) and 35.9% were the structural type. 
The inversion of chromosome No 9 was 33.3%. Among 
pregnant women, 78.7% had 1 indication, 20.6% had 
2 indications, and 0.7% had 3 or 4 indications. The cor-
relation between the results of amniotic fluid karyotype 
tests and serum tests was significant. The positive pre-
dictive value analysis showed that the more the number 
of indications is more; the positive predictive value tends 
to be maximized. Investigating indications and results of 
embryonic amniocentesis samples in the present study in-
dicates the importance of genetic screening for the iden-
tification of chromosomal abnormalities in 5.5% of preg-
nant women. The most common indication and the main 
chromosomal abnormalities detected with amniocentesis 
in our region are from positive result in maternal serum 
screening and trisomy 21, which is consistent with the 
latest findings in this area in other countries, respectively.
The degree of adaptability of initial indication and the 
results of the amniocentesis genetic tests indicated that 
serum tests have undertaken a major contribution from 
the results for amniocentesis. In the analysis of indica-
tions, if the differentiation threshold regulated for inva-
sive diagnostic tests is considered higher, probability of 
drift and the birth of babies with chromosomal defects 
will decrease.
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Análisis de las indicaciones de amniocentesis y valor predictivo positivo (VPP) de 
hallazgos citogenéticos de anomalías cromosómicas
R
es
u
m
en
A
b
st
ra
ct
 
l análisis de las causas y el alcance del diag-
nóstico inicial mediante un método invasivo 
de amniocentesis es muy importante para 
investigar las anomalías cromosómicas y otros defectos 
congénitos graves para proporcionar asesoramiento ge-
nético a mujeres embarazadas. En la provincia de Arde-
bil (noroeste de Irán), debido a fallas como infertilidad, 
abortos repetidos y anomalías embrionarias, se realizó 
un estudio para analizar muestras de líquido amniótico 
de madres embarazadas, para determinar las indicacio-
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nes de amniocentesis, para determinar la frecuencia y los 
tipos de anomalías cromosómicas y Adaptabilidad de la 
indicación de amniocentesis en mujeres embarazadas. 
Este estudio retrospectivo descriptivo analítico se realizó 
en todos los archivos de amniocentesis (715 referencias al 
único Centro de Amniocentesis de la provincia de Ardebil) 
durante 2 años. Los datos fueron recolectados median-
te el examen del expediente de pacientes. Las variables 
incluyeron: edad materna, indicación de amniocentesis, 
anomalías cromosómicas y tipo de anomalías cromosómi-
cas. Después de completar los datos, los datos se anali-
zaron mediante estadísticas descriptivas y analíticas en el 
software SPSS versión 16. El análisis de los datos mostró 
que la causa más común de amniocentesis fue un resulta-
do positivo en la detección del suero materno (58.04%). 
Se observaron anomalías cromosómicas en el 5,5%. El 
56,4% de las anomalías cromosómicas fue el tipo de cam-
bio en el número (incluida la trisomía 21) y el 35,9% fue el 
tipo estructural. La inversión del cromosoma n ° 9 fue del 
33,3%. Entre las mujeres embarazadas, el 78.7% tenía 1 
indicación, el 20.6% tenía 2 indicaciones y el 0.7% tenía 
3 o 4 indicaciones. La correlación entre los resultados de 
las pruebas de cariotipo de líquido amniótico y las pruebas 
de suero fue significativa. El análisis del valor predictivo 
positivo mostró que cuanto mayor es el número de indi-
caciones, mayor es la cantidad; El valor predictivo positivo 
tiende a ser maximizado. La investigación de las indica-
ciones y los resultados de las muestras de amniocentesis 
embrionaria en el presente estudio indica la importancia 
del examen genético para la identificación de anomalías 
cromosómicas en el 5,5% de las mujeres embarazadas. La 
indicación más común y las principales anomalías cromo-
sómicas detectadas con la amniocentesis en nuestra re-
gión provienen de resultados positivos en el cribado sérico 
materno y la trisomía 21, lo que coincide con los últimos 
hallazgos en esta área en otros países, respectivamente.
El grado de adaptabilidad de la indicación inicial y los resul-
tados de las pruebas genéticas de amniocentesis indicaron 
que las pruebas de suero han realizado una importante 
contribución de los resultados de la amniocentesis. En el 
análisis de las indicaciones, si el umbral de diferenciación 
regulado para las pruebas de diagnóstico invasivo se con-
sidera más alto, la probabilidad de deriva y el nacimiento 
de bebés con defectos cromosómicos disminuirá.
Palabras clave: trastornos genéticos, amniocentesis, in-
dicación, valor predictivo.
iagnosis of chromosomal abnormalities 
in the fetus is one of the most impor-
tant challenges in modern perinatology. 
Among the most common chromosomal abnormalities in 
infants, it can refer to 21, 18, 13 triosomes, X monosomal 
and other Aneuploidy of sex chromosomes, which these 
aneuploidy can be considered live birth for up to 95% of 
chromosomal abnormalities1. The only way to prevent the 
birth of infants with chromosomal abnormalities is pre-
natal diagnosis; these disorders are now diagnosed with 
screening tests that are a part of prenatal care around the 
world2. The prenatal screening program identifies those 
women who are at high risk for the birth of a fetus with 
trisomy 21 or another major chromosomal abnormality. 
Protocols that are currently in use include screening serum 
markers, ultrasound scans, or a combination of these two 
methods. These screening tests put mothers at risk in two 
general categories; A group is low-risk individuals who 
does not require any other test, but the other group is 
those who, after measuring the biochemical markers and 
ultrasound are in the high-risk group, and it is suggested 
to these women to perform an invasive diagnostic test 
such as amniocentesis or sampling of chorionic villus, and 
to carry out karyotype from embryonic tissues3.
Amniocentesis as the most commonly used invasive tech-
nique that allows prenatal diagnosis of chromosomal ab-
normalities in pregnant women with a high risk of em-
bryonic chromosomal abnormalities was first introduced 
in the 1960s; high diagnostic accuracy and very little risk 
of this method for embryos and mothers caused amnio-
centesis to become a gold standard for pre-natal diagno-
sis of genetic and chromosomal abnormalities. The most 
appropriate time to perform amniocentesis is 15 to 20 
weeks of pregnancy (Middle three-month method or Mid-
Trimester)5. The most important reason for amniocentesis 
in pregnancy is the evaluation of embryonic karyotype 
and the chromosomal examination of amniotic fluid cells. 
The most important indications for amniocentesis include: 
(1) high maternal age at pregnancy (35 years or older); 
(2) Presence of chromosomal abnormalities in previous 
pregnancies; (3) abnormal result of screening in the first 
or second trimester of pregnancy; (4) positive family his-
tory about a chromosomal or genetic disorder; (5) being 
carrier of parenting about one of the chromosomal ab-
normalities; (6) history of uterine infections or Rh incom-
patibility6,7. Generally, amniocentesis and chromosomal 
studies give valuable information about the chromosomal 
structure of the fetus; if the embryo has a natural chro-
mosomal structure, pregnancy can be continued without 
concern, but if there is a chromosomal abnormality, the 
probability of the fetus to consequences associated with 
that abnormality, such as mental retardation and physi-
cal abnormalities, is high, in which case it is necessary to 
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decide consciously whether to continue or discontinue 
pregnancy1,8.
Zhang et al9 in a study in 2017 in China have investigat-
ed and analyzed embryonic chromosomal abnormalities 
through amniocentesis. In this study, the results of genetic 
analysis of 40208 fetuses were evaluated by amniocentesis 
indication. Among all these samples, the positive test for 
serum maternal screening was the most common indica-
tion for amniocentesis (17536 cases; 43.67%). Abnormal 
karyotype diagnosis rate, if one of the couples had chro-
mosomal anomalies was 55.60%, in pregnant women 
with pathological findings of ultrasound was 4.43%, in 
pregnant women with high age was 2.83% and in women 
with abnormal serum screening was 2.73%. Of the embry-
os with chromosomal abnormalities, 680 cases (50.41%) 
had trisomy 13, trisomy 18 or trisomy 21, and 138 cases 
(10.23%) had sex chromosome disorder. Other 531 abnor-
mal samples included displacement anomalies, mosaicism, 
inversion, removal, increase, and marker chromosome.
Ozcan et al.10 in a study in 2017 investigated and ana-
lyzed chromosomal abnormalities in 2185 pregnancies in 
Turkey. The main indication for amniocentesis was abnor-
mal aneuploidy results for trisomy 21, then older maternal 
age, and embryonic structural abnormalities.
Chang et al11 in a study in Taiwan in 2016, investigated 
chromosomal abnormalities among 31,556 amniocentesis 
cases. The findings of this study showed that 3 common 
indications for amniocentesis were high maternal age 
(75.11%), abnormal result of serum maternal screening in 
the second trimester (13.22%), and abnormal ultrasound 
findings (8.00%). Down syndrome was the most common 
autosomal abnormality (25.74%). Turner syndrome was 
the most common sex chromosome abnormality (7.04%). 
Of structural anomalies, 26.93% were balanced displace-
ments and 17.10% were unbalanced displacements. The 
largest part of embryonic chromosomal abnormalities was 
found in cases where parents were also affected by chro-
mosomal abnormalities (38.02%).
Mademont-Soler et al12 in a study in 2011 investigated the 
results of amniotic fluid samples. In this study, the results 
of the analysis of 29,883 amniotic fluid samples were in-
vestigated. The incidence of chromosomal abnormalities 
was 2.9%. In the meantime, 48.1% had classical autoso-
mal aneuploidy that trisomy 21 was the most common. 
The main indications for amniocentesis, prenatal screen-
ing test and maternal age were high. The reasons for re-
ferring pregnant women to amniocentesis with the high-
est positive predictive value were increased thickness of 
the fluid behind the neck of fetus (9.2%) and ultrasound 
abnormalities (6.6%).
Nishiyama et al.13 in a study in 2015 in Japan investigated 
the frequency and type of abnormal karyotype in 28,983 
amniotic fluid samples collected before the 22nd week 
of pregnancy. This study was conducted at the national 
level and retrospectively. Abnormal karyotype occurrence 
was 6%.
Given that chromosomal abnormalities are one of the 
main causes of congenital severe defects, it is evident that 
the study and analysis of amniotic fluid samples and the 
occurrence and type of chromosomal abnormalities has a 
great importance for the genetic counseling of pregnant 
women; The numerous studies that have been carried 
out in recent years in this field show the importance of 
studying in this regard9-13; however, in the region, there 
are no previous studies on frequency and abnormal type 
of karyotype in the region’s population identified with 
amniocentesis. The aim of this study was to investigate 
and analyze the amniotic fluid samples of pregnant moth-
ers in Ardabil, to determine amniocentesis indications, to 
determine the frequency of anomalies, to determine the 
type of chromosomal abnormalities, and to determine 
the types of chromosomal abnormalities among pregnant 
women and the degree of adaptability of amniocentesis 
among pregnant women.
his retrospective descriptive-analytic study was 
conducted on all amniocentesis files (715 refer-
rals to the only Amniocentesis Center of Ardebil 
province) over 2 years. Data were collected by examining 
the patients’ file. The variables included: maternal age, in-
dication of amniocentesis, chromosomal anomalies, and 
type of chromosomal abnormalities. Positive predictive 
value (PPV) was calculated based on the degree of ad-
aptation of the initial diagnosis based on the indications 
and the result of cytogenetic tests of the samples was 
calculated from the amniotic fluid.
After completing the data, the data were analyzed using 
descriptive and analytical statistics in SPSS software ver-
sion 16. To analyze the data, descriptive statistics methods 
including classification of information, conversion of clas-
sified information to frequency table, setting frequency 
percentage and drawing diagram were used. In order to 
adapt, Chi square test and ratio test was used.
Amniocentesis indications among pregnant women:
Figure 1 shows the amniocentesis indications among 
pregnant women studied. It is observed that among 715 
pregnant women, who were under amniocentesis, 78.7% 
had 1 indication, 20.6% had 2 indications, and 0.7% had 
3 or 4 indications. Meanwhile, the most common cause 
of amniocentesis was a positive result in maternal serum 
screening (58.04%). Other common causes were as the 
following: positive result in serum maternal screening 
and increasing Nuchal Translucency(11.5%); self-patient’s 
request (4.9%); increasing Nuchal Translucency(4.62%); 
And abnormal findings in ultrasound (3,78%). Table 1.
Frequency of chromosomal abnormalities among preg-
nant women:Among 715 pregnant women who were 
under amniocentesis, chromosomal anomalies were 
5.5% (Fig. 3).
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Table 2. Amniocentesis indications among pregnant women
PercentIndication 
58.04%Positive result in maternal serum screening
1 indication
4.90%Patient’s request
4.62%increasing Nuchal Translucency
3.78%Abnormal findings in ultrasound
2.80%
Bad obstetric history (previous history of abortion, history of stillbirth or neonatal death, 
anomaly)
0.84%Mother’s high age (over 35 years old at birth)
1.40%Parent chromosomal abnormalities
2.38%No Indication
11.05%Positive result in maternal serum screening + Increasing Nuchal Translucency
2 indications 
3.22%Positive result in maternal serum screening + high maternal age
1.96%Positive result in maternal serum screening + Parental chromosomal abnormalities
1.40%Positive result in maternal serum screening + Abnormal findings in ultrasound
0.84%Positive result in maternal serum screening + bad obstetric history
0.28%High maternal age + Abnormal findings in ultrasound
0.14%High maternal age + Increasing Nuchal Translucency
0.14%High maternal age + Parental chromosomal abnormalities
0.14%High maternal age + bad obstetric history
0.98%Abnormal findings in ultrasound+ Increasing Nuchal Translucency
0.28%bad obstetric history+ Abnormal findings in ultrasound
0.14%bad obstetric history+ Increasing Nuchal Translucency
0.28%
Increasing Nuchal Translucency+ Abnormal findings in ultrasound+ Abnormal findings in 
ultrasound
3 or 4 indications 
0.14%
Positive result in maternal serum screening + bad obstetric history+ Increasing Nuchal 
Translucency
0.14%
Positive result in maternal serum screening + Abnormal findings in ultrasound + Increasing 
Nuchal Translucency
0.14%
Positive result in maternal serum screening + bad obstetric history+ Parental chromosomal 
abnormalities+ Increasing Nuchal Translucency
100%Sum 
Figure 1. Frequency of amniocentesis indications among 
pregnant women
Figure 3. Frequency of chromosomal abnormalities 
among pregnant women
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Chromosome abnormalities among pregnant women:
Among the studied samples with chromosome anomalies, 
56.4% were numerable type and 35.9% were structural 
type; also, 7.7% were chimeric (Table 3).
A variety of chromosomal abnormalities is inserted in 
cases with abnormalities in Table 3. In general, the most 
common abnormality is trisomy 21 (35.9%), and then, the 
inversion of chromosome number 9 (33.3 Percent). Other 
abnormalities are as follows: Chimera (7.69%), transloca-
tion (5.13%), and then trisomy 18, trisomy 13, Klinefel-
ter’s syndrome, mosaicism Klinefelter’s syndrome, Turner 
syndrome, Trisomy 21 mosaicism, and Triple X syndrome 
of mosaicism(each of which is 2.56%).
Chromosomal abnormalities among pregnant women are 
shown in Table 4 in terms of indications of amniocente-
sis. Investigating diagnostic indications indicates that the 
positive result in the mother’s serum screening was the 
highest indication for the initial diagnosis and was almost 
a good indication for most chromosomal abnormalities. 
Inversion of chromosomes had a high frequency, which 
was firstly diagnosed by the same indicator. Chimera 
abnormalities are also diagnosed with indicators of ab-
normal findings in ultrasonography + increasing Nuchal 
Translucency and positive result in maternal serum screen-
ing + abnormal findings in ultrasonography + increasing 
Nuchal Translucency.
Table 3. Chromosome abnormalities among pregnant women
KaryotypePercentAbnormality
7 cases (47, XX, +21)
7 cases (47, XY, +21)
35.90%Trisomy 21
Numerable
45, XX, reln (13;14)2.56%
Robertsonian 
Translocation
46, XY /47, XY(+21)2.56%Trisomy 21 mosaicism
47, XY, +182.56%Trisomy 18
47, XY, +132.56%Trisomy 13
47, XXY2.56%Klinefelter
47, XXY/46, XY2.56%MosaicismKlinefelter
45, X2.56%Turner syndrome
46, XX/47, XXX2.56%
Triple X syndrome of 
mosaicism
8 cases (46, XX, inv(9))
5 cases (46, XY, inv(9))
33.33%
The inversion of 
chromosome 9
Structural
46, XX, t(7p/14p)2.56%Interchange
46, XX/46, XY7.69%Chimera
-100%Sum
Table 4: Chromosome abnormalities among pregnant women examined in terms of amniocentesis indication
Trisomy 21(34.8%)-(100%)(50%)-(40%)---(35.9%)
The inversion of chromosome 9(34.8%)(100%)-(50%)-(20%)(100%)--(23.3%)
Chimera(4.3%)------(100%)(100%)(7.7%)
Interchange(4.3%)--------(2.6%)
Robertsonian Translocation(4.3%)--------(2.6%)
Trisomy 21 mosaicism(4.3%)--------(2.6%)
Trisomy 18-----(20%)---(2.6%)
Trisomy 13(4.3%)--------(2.6%)
Klinefelter(4.3%)--------(2.6%)
MosaicismKlinefelter----(100%)----(2.6%)
Turner syndrome(4.3%)--------(2.6%)
Triple X syndrome of mosaicism-----(20%)---(2.6%)
Table 5. Indications of amniocentesis and positive predictive value (PPV)
Positive predictive 
value (PPV)
Indication of amniocentesis
5.5
20
9.1
8.7
50
6.3
7.1
14.3
100
Positive result in maternal serum screening:
Parental chromosomal abnormalities:
Increasing Nuchal Translucency:
Positive result in maternal serum screening + high maternal age
High maternal age + Abnormal findings in ultrasound
Positive result in maternal serum screening + Increasing Nuchal Translucency
Positive result in maternal serum screening + Parental chromosomal abnormalities:
Abnormal findings in ultrasound+ Increasing Nuchal Translucency
Positive result in maternal serum screening + Abnormal findings in ultrasound + Increasing Nuchal Translucency
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The positive predictive value (PPV) for various indications 
is shown in Table 5. The most positive predictive value was 
related to the positive result in the combined indications 
of maternal serum screening + abnormal findings in ul-
trasonography + increasing Nuchal Translucency and the 
lowest predictive value related to the positive result in ma-
ternal serum screening.
 
ytogenetic diagnosis during the period of 
prenatal has been known for over 40 years 
as a reliable method for the identification 
of pre-birth of fetal chromosomal abnormalities; specifi-
cally, amniocentesis in the late 1960s has been developed 
as a cytogenetic prenatal diagnosis tool27 and it is now 
used extensively in the field of obstetrics and gynecology. 
Considering that chromosomal abnormalities are one of 
the main causes of congenital severe defects and the study 
and analysis of amniotic fluid samples and knowledge of 
occurrence and type of chromosomal abnormalities is very 
important for the genetic counseling of pregnant women.
The findings of this study showed that the frequency of 
chromosomal abnormalities detected by amniocentesis in 
the population was 5.5%; in other words, amniocente-
sis among the high risk cases identified by the pregnancy 
screening test identified 5.5% as the cases of chromo-
somal abnormalities. The frequency of chromosomal 
abnormalities detected by amniocentesis in the study of 
Zhang et al.9 in 2017 in China was 3.36%, in the study 
by Chang et al.11 in 2016 in Taiwan was 2.42%, in the 
study by Nishiyama et al.13 in Japan in 2008 was 6%, and 
in Mademont-Soler et al.12, in Spain in 2011 was reported 
2.9%. It is observed that the reported range for frequency 
of chromosomal abnormalities detected with amniocen-
tesis in different countries is between 2.42% and 6%, 
which our study’s finding is in this range.
Our study findings about the causes of amniocentesis 
showed that the most common indication was the posi-
tive result in maternal serum screening, which the cause 
of more than half of the amniocentesis cases in our popu-
lation was formed by this indication (58.04%). The most 
common indication of amniocentesis in studies by Zhang 
et al.9 in China and Mademont-Suler et al.12 in Spain 
was also the positive result in maternal serum screening 
(43.7% and 44.1% of all items) that match our findings 
in this respect.
But the most common cause of amniocentesis in stud-
ies by Chang et al.11 in Taiwan and Nishiyama et al.13 in 
Japan has been reported high maternal age that are dif-
ferent from our study. It should be noted that in the early 
years of the introduction of amniocentesis as a prenatal 
cytogenetic diagnostic tool, “high maternal age” was the 
main cause of reference for amniocentesis, since positive 
association between embryonic aneuploidy and maternal 
age was well specified28,29.
Today, however, the high maternal age is considered as 
an unconventional separate criterion12, and biochemical 
markers such as serum alpha-fetoprotein levels, Human 
Chorionic Gonadotropin, and Pregnancy-associated plas-
ma protein A associated with maternal age reach a high 
rate of identification for Chromosomal abnormalities30. In 
our study, “high maternal age” was considered only as 
a single indication of amniocentesis in only (0.84%) of 
pregnant women, while in 28 other cases with causes, 
such as “positive result in maternal serum screening”, 
“Abnormal findings in ultrasound”, “Increasing Nuchal 
Translucency”, “Parental chromosomal abnormalities”, 
and “Bad obstetric history” was raised as an indication of 
amniocentesis.
In the present study, the prevalence of numerical chro-
mosomal abnormalities was higher than structural abnor-
malities (56.4% vs. 35.9%). In all previous studies, the 
prevalence of numerical chromosomal abnormalities has 
been reported more, including in Zhang et al.9 in China, 
63.1% of the abnormalities were the numerical type and 
36.99% were the structural type ; In Chang et al.11, in 
Taiwan, 56.5% of abnormalities were the numerical type 
and 43.5% were the structural type; in Chang Made-
mont-Suler et al.12 in Spain, 61.3% of abnormalities were 
the numerical type and 26.2% were structural type and 
in the study of Nishiyama et al.13, in Japan, 65.6% of the 
abnormalities were numerical type and 18.4% were the 
structural type.
In addition, the most common abnormality among all the 
chromosomal abnormalities observed in the women stud-
ied in this study was trisomy 21, which included 35.9% 
of all cases. Similar to our study, in the study of Ozjan et 
al.10 in 2017 in Turkey, trisomy 21 was the most common 
aneuploidy. Also, in other similar studies, trisomy 21 has 
been reported as the most common chromosomal abnor-
malities, including studies by Chang et al in Taiwan (with 
a frequency of 25.74%), Zhang et al. 9] in China (with 
a frequency of 37.44%), Mademont-Suler et al in Spain 
(with a frequency of 37.9%), and Nishiyama et al.13 in 
Japan (with a frequency of 43.5%).
It is observed that our finding that trisomy 21 is the most 
important chromosomal abnormality detected with am-
niocentesis is consistent with results of other studies and 
support them. In general, Trisomy 21 (Down syndrome) is 
clearly the most common and most known chromosomal 
abnormality that affects nearly one in every 800 live births 
to Down syndrome. The syndrome was first clinically de-
scribed by Langdon Down in 1866, and in 1959, it was 
found that most affected children have 47 chromosomes 
(additional chromosomes 21). Studies show that a high 
percentage of pregnancies with Trisomy 21 abort spon-
taneously and only about 20-25% of these pregnancies 
survive until birth. About a quarter of live births have heart 
defects that die before they are one year old. Among the 
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babies who survive, the risk of leukemia and blood can-
cers increases 12 times. Also, among survivors, the risk of 
Alzheimer’s and dementia increases to a very high rate31.
The second most common chromosomal abnormality in 
the present study, which was under amniocentesis, was 
inversion of chromosome 9 (33.3%). The prevalence of 
inversion abnormality in studies by Mademont-Suler et 
al.12 in Spain was 7.5 percent, Nishiyama et al.13 in Japan, 
3.8 percent, Chang et al.11 in Taiwan, 22.10 percent, and 
Zhang et al.9 in China was reported 4/3 percent which is 
less than our study. Chromosome inversion 9 is a recom-
binant that may be accidentally reported in well-healthy 
individuals. Its prevalence in the general population is 
1-1.65%. Despite the categorization of this recombinant 
as a small chromosomal disorder and its lack of associa-
tion with abnormal phenotype, many reports indicate its 
relation with reducing fertility, frequent abortion, increas-
ing chance of chromosomal abnormalities, and intrauter-
ine fetal death. The incidence of this disorder is not re-
lated to the gender, as well as the reduction in fertility in 
36% of those who carry the inversion of chromosome 9 
can be seen15-19.
Investigating indications and results of embryonic amnio-
centesis samples in the present study indicates the impor-
tance of genetic screening for the identification of chro-
mosomal anomalies in 5.5% of pregnant women. Our 
study also showed that the most common indication and 
the most important chromosomal abnormalities detected 
with amniocentesis is the positive result in maternal serum 
screening and trisomy 21, which is consistent with the lat-
est findings in this area in other countries. Our findings 
can provide useful information for the genetic counseling 
of pregnant women in Ardabil, and it is recommended 
that in the analysis of indications, instead of selecting 1% 
of those who are at risk for amniocentesis; its contribu-
tion should be considered more as some countries. In the 
analysis of indications, if the differentiation threshold reg-
ulated for invasive diagnostic tests is considered higher, 
the probability of drift and the birth of infants with chro-
mosomal defects will decrease.
Given the results of the karyotype of amniocentesis sam-
ples and the comprehensive assessment of embryo devel-
opment with ultrasound, genetic counseling can inform 
parents about the clinical outcomes of anomaly and ther-
apeutic options and guide them to continue pregnancy or 
end it according to the law.
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